JHL Biotech

We are developing a vast pipeline of several proprietary biosimilars through experienced process optimization, an unwavering commitment to quality, and with innovative/cost-effective manufacturing infrastructure. We license-in innovative new molecules for co-development that we believe offer long-term benefits and can address global unmet medical needs. In paving the way to becoming an industry leader in biologics manufacturing, innovation is key. Founded in 2012, Eden Biologics is an innovator in biopharmaceuticals that utilizes breakthrough engineering and process technologies to provide high quality and affordable biosimilar medicines to patients in need and a formidable CDMO player for global and regional clients. Eden has submitted IND/CTA’s to over 20+ countries/regions and has passed numerous Regulatory Audits/Inspections, including from the Taiwan FDA and EU Qualified Person (QP).